Thus, our data revealed multiple enriched pathways within ALDH+ CRC cells that could potentially be targeted to eliminate the CSC population within the tumour, with the aim of treatment of disseminated disease and prevention of recurrences [9]. This evidence concerns the gene LDHA and colorectal carcinoma.